Nephrotoxicity of vancomycin, alone and with an aminoglycoside

Journal of Antimicrobial Chemotherapy

Volumn 25, Issue 4, 1990, Pages 679-687

  Rybak, Michael J ^a,d   Albrecht, Lisa M ^c   Boike, Steven C ^a,d   Chandrasekar, Pranatharthi H ^a,b  

^a Department of Medicinal Chemistry   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d DETROIT RECEIVING HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CREATININE; GENTAMICIN; VANCOMYCIN;

ARTICLE; BACTERIAL INFECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SERUM;

ADULT; ANALYSIS OF VARIANCE; ANTIBIOTICS, AMINOGLYCOSIDE; ANTIBIOTICS, COMBINED; FEMALE; HUMAN; KIDNEY DISEASES; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; VANCOMYCIN;

EID: 0025307266     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/25.4.679     Document Type: Article

References (22)

1. Cheung, R. P. F. & DiPiro, J. T. (1986). Vancomycin; an update. Pharmacotherapy 6, 153-69.
2. Cimino, M. A., Rotstein, C., Slaughter, R. L. & Emrich, L. J. (1987). Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy. American Journal of Medicine 83, 1091-7.
3. Cockcroft, D. W. & Gault, M. H. (1976). Prediction of creatinine clearance from serum creatinine. Nephron 16, 31-41.
4. Cooper, G. L. & Given, D. B. (1986). The development of vancomycin. In Vancomycin: A Comprehensive Review of 30 Years of Clinical Experience, pp. 1-5. Park Row Publications, Indianapolis, IN.
5. Dahlgren, J. G., Anderson, E. T. & Hewitt, W. L. (1975). Gentamicin blood levels: a guide to nephrotoxicity. Antimicrobial Agents and Chemotherapy 8, 58-62.
6. Farber, B. F. & Moellering, R. C. (1983). Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrobial Agents and Chemotherapy 23, 138-41.
7. Griffiths, R. S. (1984). Vancomycin use—an historical review. Journal of Antimicrobial Chemotherapy 14, Suppl. D, 1-5.
8. Houghton, D. C., Hartnett, M., Campbell-Boswell, M., Porter, G. A. & Bennett, W. M. (1976). A light and electron microscopic analysis of gentamicin nephrotoxicity in rats. American Journal of Pathology 82, 589-612.
9. Hsu, C. H., Kurtz, T. & Weller, J. (1977). In vitro uptake of gentamicin by rat renal cortical tissue. Antimicrobial Agents and Chemotherapy 12, 192-4.
10. Lemer, S. A., Schmitt, B. A., Seligsohn, R. & Matz, G. J. (1986). Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. American Journal of Medicine 80, Suppl. 6B, 98-104.
11. Levine, D. P., Cushing, R. D., Jui, J. & Brown, W. J. (1982). Community-acquired methidllin- resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Annals of Internal Medicine 97, 330-8.
12. Mane, R., Schulz, E., Anders, T. & Sack, K. (1984). Renal tolerance and pharmacokinetics of vancomycin in rats. Journal of Antimicrobial Chemotherapy 14, 253-60.
13. Matzke, G. R., Lucarotti, R. L. & Shapiro, H. S. (1983). Controlled comparison of gentamicin and tobramycin nephrotoxicity. American Journal of Nephrology 3, 11-7.
14. Mellor, J. A., Kingdom, J., Cafferkey, M. & Keane, C. T. (1985). Vancomycin toxicity: a prospective study. Journal of Antimicrobial Chemotherapy 15, 773-80.
15. Rybak, M. J. & Boike, S. C. (1986). Monitoring vancomycin therapy. Drug Intelligence and Clinical Pharmacy 20, 757-61.
16. Rybak, M. J., Frankowski, J. J., Edwards, D. J. & Albrecht, L. M. (1987). Alanine ami no peptidase and β-micro globulin excretion in patients receiving vancomycin and gentamicin. Antimicrobial Agents and Chemotherapy 31, 1461-4.
17. Saravolatz, L. D., Markowitz, N., Arlring, L., Pohlod, D. & Fisher, E. (1982). Methicillin- resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Annals of Internal Medicine 96, 11-6.
18. Sorrell, T. C. & Collignon, P. J. (1985). A prospective study of adverse reactions associated with vancomycin therapy. Journal of Antimicrobial Chemotherapy 16, 235-41.
19. Sorrell, T. C., Pack ham, D. R., S hanker, S., Foldes, M. & Munro, R. (1982). Vancomycin therapy for methiciIlin-resistant Staphylococcus aureus. Annals of Internal Medicine 97, 344-50.
20. Watanakunakom, C. (1982). Treatment of infections due to methicillin-resistant Staphylococcus aureus. Annals of Internal Medicine 97, 376-8.
21. Wold, J. S. & Tumipseed, S. A. (1981). Toxicology of vancomycin in laboratory animals. Reviews of Infectious Diseases 3, Suppl., S224-9.
22. Wood, C A., Kohlhepp, S. J., Kohnen, P. W., Houghton, D. C. & Gilbert, D. N. (1986). Vancomycin enhancement of experimental tobramycin nephrotoxicity. Antimicrobial Agents and Chemotherapy 30, 20-4.